Malaysia will be distributing special remuneration aid for Malaysians and non-Malaysians who were inoculated by the Covid-19 vaccine and were affected by serious side effects under the National Covid-19 Immunisation Programme.
Putrajaya has launched the special Covid-19 vaccine injury scheme under the provision of the Special Committee on Covid-19 Vaccine Supply (JKJAV) with an initial fund of RM 10 million for this purpose.
“RM50,000 if the side effects are serious for vaccine recipients who require prolonged hospital treatment and RM500,000 if permanent disability or death due to Covid-19 vaccine.
The Government has agreed to provide a start -up fund of RM10 million under the National Disaster Relief Trust Fund (KWABBN) managed by the National Disaster Management Agency (NADMA) for the purpose of payment of this special financial assistance,” Health Minister, Dr. Adham Baba said.
The Ministry of Health (MOH) has established three committees to monitor and assess the adverse effects due to the immunisation and safety issues which are related to the Covid-19 vaccine.
Firstly, Jawantankuasa Farmakovigilans Khas Bagi Pemantauan Vaksin Covid-19 to monitor an adverse event following immunisation (AEFI). Secondly, Jawantankuasa Teknikal Perubatan to give confirmation the case has any relations to the vaccine side effects. Lastly, Jawantankuasa Induk Bantuan Khas Kewangan Kesan Mudarat Vaksin Covid-19 to approve the remuneration aid based on the two previous mentioned committees.
“These figures are higher than most private insurance schemes. This is to instil confidence in the vaccination programme by highlighting the rarity of the AEFI.
To date, no deaths have been directly attributed to the Covid-19 vaccine,” Director of Communications, Policy, and Strategy at the Ministry of Science, Technology, and Innovation (MOSTI), Dimishtra Sittampalam tweeted.
